SynCardia makes Michael Garippa president
This article was originally published in Clinica
Executive Summary
Michael Garippa has become the president of SynCardia Systems, an artificial heart specialist. He will concentrate on aiding the firm’s sales, clinical support, training and marketing. Mr Garippa was previously the president and CEO of fellow cardiovascular company TandemHeart for eight years. SynCardia (Tucson, Arizona) sells the SynCardia temporary total artificial heart. The company says that there have been more than 850 implants of the device, which is approved by the US FDA and Health Canada, and has been CE marked for sale in Europe.